EMA: HMPC Meeting Report published
Recommendation

Thursday, 3 September 2026 9 .00 - 17.00 h
Establishment, Use and Maintenance of Analytical Reference Substances
On 27 November, 2017, the EMA's Committee on Herbal Medicinal Products (HMPC) published the HMPC meeting report about their meeting held from 20-21 November, 2017.
One of the meeting's key issues was the reflection paper on "Polycyclic Aromatic Hydrocarbons".
The HMPC decided for the comments received on reflection paper EMA/HMPC/300551/2015 to be published. HMPC approves the step-by-step approach suggested by the participants. The parties involved agreed to collect and share data.
Presently, the data available on contamination levels in herbal medicinal products is still very limited and therefore inadequate to serve as a basis for specific requirements and standardised controls. HMPC will also consider requirements from the food sector when determining limits for updating quality guidelines for herbal medicines in the future.
It was further decided by the HMPC that the Q&A document on herbal medicinal products is to be supplemented by a question on the difference between European monographs on herbal medicines and the individual "Product SmPCs".
For more deailed information please see the comprehensive "HMPC meeting report on European Union herbal monographs, guidelines and other activities" as well as the Herbal medicinal products: questions and answers.
Related GMP News
01.07.2026Several FDA Warning Letters and Untitled Letters on Asbestos Testing of Talc in OTC Drug Products
24.06.2026Analytical Quality Group Developments January through April 2026
17.06.2026BioPhorum Publishes a Roadmap for QC Sample Test Execution
03.06.2026EMA Provides an Outlook on the Product-Specific Bioequivalence Guidelines Expected in 2026
03.06.2026FDA Warning Letter: Missing Method Validation - From a QC Topic to a Market-Access Problem
28.05.2026WHO Working Document on Bioequivalence open for Public Consultation


